Association of 5-HT3 Receptor Gene Polymorphism With the Efficiency of Ondansetron for Postoperative Nausea and Vomiting

Yonsei University

Status: Completed

Conditions: Post Operative Nausea and Vomiting

Treatments: Dietary Supplement: administration of ondanstron and screening of genomic DNA

Study type: Interventional

Funder types: Other

Identifiers

NCT01657786

4-2008-0075

Details and patient eligibility

About

Postoperative nausea and vomiting (PONV) is a common and distressing complication in patients undergoing general anesthesia. However, although 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists have significantly reduced PONV, it is reported that over 35% of patients treated with ondansetron experience PONV. Though the cause of failure in ondansetron treatment is not clear, the investigators assumed that polymorphism in the 5-HT3 receptor gene would contribute to such inter-individual variation. In this study, the investigators examine whether the polymorphisms of 5-HT3 receptor gene affect the efficacy of ondansetron to prevent PONV in patients undergoing general anesthesia for laparoscopic surgery.

Enrollment: 198 patients

Sex: All

Ages: 20 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients (20-90 years of age) scheduled for undergoing laparoscopic surgery undergoing general anesthesia

Exclusion criteria

• Patients with previous history of drug allergy,
• administration of antiemetic drugs within 24 hours,
• nausea/vomiting within 24 hours and liver or kidney disease

Trial design

198 participants in 1 patient group

Ondansetron administration group

Experimental group

Treatment:

Dietary Supplement: administration of ondanstron and screening of genomic DNA